Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
February 5, 2011
DPP-IV-resistant, long-acting oxyntomodulin derivatives
Alessia Santoprete, Elena Capitò, Paul E Carrington, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide
Philippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Science (New York, N.Y.)
|
February 21, 2004
Regulation of fasted blood glucose by resistin
Ronadip R Banerjee, Shamina M Rangwala, Jennifer S Shapiro, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
Joel P Berger, Ranabir SinhaRoy, Alessandro Pocai, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Hui Huang, Sanath K Meegalla, James C Lanter, et al.
Diabetes
|
July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice
Alessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
The New England Journal of Medicine
|
July 31, 2024
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
Elisa Fabbrini, Brian Rady, Anastasiya Koshkina, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia
Renata M Oballa, Liette Belair, W Cameron Black, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 7, 2024
Pan AMPK Activation Protects Tubules in Rat Ischemic Acute Kidney Injury
Henriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2025
Pan AMPK activation protects tubules in rat ischemic acute kidney injury
Henriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
February 5, 2011
DPP-IV-resistant, long-acting oxyntomodulin derivatives
Alessia Santoprete, Elena Capitò, Paul E Carrington, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide
Philippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Science (New York, N.Y.)
|
February 21, 2004
Regulation of fasted blood glucose by resistin
Ronadip R Banerjee, Shamina M Rangwala, Jennifer S Shapiro, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
Joel P Berger, Ranabir SinhaRoy, Alessandro Pocai, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Hui Huang, Sanath K Meegalla, James C Lanter, et al.
Diabetes
|
July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice
Alessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
The New England Journal of Medicine
|
July 31, 2024
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
Elisa Fabbrini, Brian Rady, Anastasiya Koshkina, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia
Renata M Oballa, Liette Belair, W Cameron Black, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 7, 2024
Pan AMPK Activation Protects Tubules in Rat Ischemic Acute Kidney Injury
Henriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2025
Pan AMPK activation protects tubules in rat ischemic acute kidney injury
Henriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.
Page
of 7